Meyka Pro banner
St. Jude Medical, Inc.

Stay Updated with the Latest St. Jude Medical, Inc. STJ News in Real Time

Find STJ news now at Meyka AI. Stay informed with the latest St. Jude Medical, Inc. stocks updates, including price news, market analysis, and expert insights.

STJNYSE
HealthcareMedical - Equipment & Services
$80.82
$0.00(0.00%)
U.S. Market opens in 58h 3m
Man Charged With Six Counts of Rape After Brisbane Attack, Arrested at Crime Scene
📅 in about 3 hours

Man Charged With Six Counts of Rape After Brisbane Attack, Arrested at Crime Scene

Jacob Dave Henry Hauraki, 32, charged with six counts of rape after allegedly attacking a woman on her morning walk in Brookfield, Brisbane on August 21. Police arrested him after he returned to the crime scene.

Read more 12
Block Ordered to Pay $120M CFPB Restitution for Cash App Fraud Failures
📅 1 hour ago

Block Ordered to Pay $120M CFPB Restitution for Cash App Fraud Failures

Block must pay $45M to states and $75M-$120M to Cash App users via CFPB restitution for fraud failures, account security gaps, and inadequate customer support.

Read more 12
OpenAI’s iMessage Plugin Raises Privacy Stakes for Apple on August 21
📅 10 hours ago

OpenAI’s iMessage Plugin Raises Privacy Stakes for Apple on August 21

OpenAI rolled out an Apple Messages plugin for ChatGPT on Mac that can read, search, and send texts. The feature raises privacy questions despite local processing claims and default approval gates.

Read more 12
Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge
📅 14 hours ago

Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge

Bitcoin surged 8% to $74,982 on Friday, August 21, 2026, extending a powerful weekly rally. The cryptocurrency has now climbed nearly 20% since Monday, fueled by a surprise US Treasury policy shift. Ethereum jumped toward $2,300, gaining roughly 18% in 24 hours, while XRP surged past $1.25.  Total crypto market capitalization reached $2.56 trillion, up…

Read more 12
Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B
📅 16 hours ago

Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B

Alphabet is spending more to keep up with demand for artificial intelligence. On July 22, 2026, the Google parent raised its 2026 capital expenditure forecast to $195 billion-$205 billion, up from $180 billion-$190 billion. The increase comes as Google Cloud revenue jumped 82% to $24.8 billion in the second quarter. As AI demand drives higher…

Read more 12
Japan Ends 45-Hour Overtime Cap in September, Allowing Up to 100 Hours Monthly
📅 1 day ago

Japan Ends 45-Hour Overtime Cap in September, Allowing Up to 100 Hours Monthly

Japan ends blanket 45-hour overtime guidance in September, allowing companies with special clauses to permit up to 100 hours monthly. Labor inspectors will focus on worker health protections instead.

Read more 12
Moderna Soars 122% on Melanoma Vaccine Breakthrough, August 21
📅 1 day ago

Moderna Soars 122% on Melanoma Vaccine Breakthrough, August 21

Moderna stock jumps 122% after announcing its personalized mRNA melanoma vaccine met Phase 3 trial goals. The vaccine reduced cancer recurrence and spread when combined with Merck’s Keytruda.

Read more 12
Hays Stock Rises 0.52% as Recruiter Cuts Dividend 65% Amid Hiring Slump
📅 1 day ago

Hays Stock Rises 0.52% as Recruiter Cuts Dividend 65% Amid Hiring Slump

Hays stock edged up 0.52% on August 20, 2026, after the recruitment giant posted FY26 results. The company cut its total annual dividend by 65%, from 1.24 pence to 0.44 pence per share. Net fees fell as hiring activity stayed weak across Hays’ key markets. Investors focused on cost cuts and stabilizing margins rather than…

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20
📅 1 day ago

Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20

Moderna jumps 177% and Merck rises 12% after their mRNA cancer vaccine meets Phase 3 endpoints for melanoma. The combo reduced cancer recurrence and spread in over 1,100 patients.

Read more 12

STJ News FAQ